The two cases covered here, which outline noncanonical AR cistrome-dependent mechanisms of resistance to Enzalutamide treatment, raise important questions about lineage plasticity, epigenetic modifications, and chromatin remodeling at this stage of PCa. This evidence concerns the gene AR and posterior cortical atrophy.